series-c-plus
Stage
2016
Founded
2
Investors
About
Cytovale develops rapid blood-based diagnostic tests for critical care, focusing on identifying sepsis and other acute conditions by measuring immune cell responses at the single-cell level using advanced cytometry and microfluidics technologies.
Explore Cytovale's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.